Apis Capital Advisors, LLC Myovant Sciences Ltd. Transaction History

Apis Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $951,200 - $1.68 Million	82,000 New	82,000 $1.47 Million
Q2 2022 Aug 12, 2022	SELL	$7.78 - $14.69 $311,200 - $587,600	-40,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.38 - $16.4 $455,200 - $656,000	40,000 New	40,000 $533,000
Q1 2021 May 14, 2021	SELL	$20.46 - $25.18 $2.66 Million - $3.27 Million	-130,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $1.79 Million - $3.59 Million	130,000 New	130,000 $3.59 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.